Psychiatric Comorbidity Reduces Quality of Life in Chronic Methadone Maintained Patients
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Despite the efficacy of methadone maintenance treatment (MMT), opioid dependence still involves severe impairment offunctioning and low quality of life. This study examines the influence of the psychiatric comorbidity of MMT patients on their quality of life. A total of 193 middle‐aged patients in long‐term MMT were assessed for current and lifetime Axis I psychiatric disorders, substance use disorders, and personality disorders using the MINI, the CIDI‐SAM, and the SIDP‐IV. Quality of life (Qol) was assessed using the EQ‐5D. Psychiatric comorbidity was documented in 78% of the patients. Mood disorders (60%) and anxiety disorders (46%) were the most common diagnoses. Additional substance use disorders were diagnosed in 70% of the MMT patients. While a probable personality disorder was documented for 65% of the patients, 66 of these patients actually showed an antisocial personality disorder. Qol was severely diminished to a level comparable to that for patients with chronic psychiatric and/or somatic disorders. Multivariate analyses showed the occurrence of comorbid psychiatric disorders to explain about 32% of the variance in Qol. The quality of life for MMT patients is generally low. The present results showed a high rate of psychiatric comorbidity for this patient group with mood disorders, additional substance use disorders, and personality disorders occurring in particular. Such comorbid psychopathology substantially affects quality of life. The negative influence of comorbid psychopathology on quality of life is an important reason to provide additional mental health services for MMT patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Carpentier et al., 2009
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
A 33-Year Follow-up of Narcotics Addicts
Hser, Y.-I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.503 · Cited by 848
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00073-2 · Cited by 617
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 585
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., Davoli, M., & Breen, R. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209 · Cited by 531
The Reliability of the CIDI‐SAM: a comprehensive substance abuse interview
COTTLER, L. B., ROBINS, L. N., & HELZER, J. E. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03060.x · Cited by 433
Role of maintenance treatment in opioid dependence
Ward, J., Hall, W., & Mattick, R. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05356-2 · Cited by 424
The National Treatment Outcome Research Study (NTORS): 4–5 year follow‐up results
Gossop, M., Marsden, J., Stewart, D., & Kidd, T. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00296.x · Cited by 401
Prognostic Significance of Psychopathology in Treated Opiate Addicts: A 2.5-Year Follow-up Study
Rounsaville, B. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800080025004 · Cited by 372
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub4 · Cited by 370
(2007) · PubMed · Cited by 324
The Role of Psychiatric Disorders in Predicting Drug Dependence Treatment Outcomes
Compton III, W. M., Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., & Spitznagel, E. L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.890 · Cited by 309
Treatment of patients with substance use disorders, second edition. American Psychiatic Association.
Kleber, H. D., Weiss, R. D., Anton, R. F., George, T. P., Greenfield, S. F., Kosten, T. R., O’Brien, C. P., Rounsaville, B. J., Strain, E. C., Ziedonis, D. M., et al. (2006) · PubMed · Cited by 265
ROSS, J., TEESSON, M., DARKE, S., LYNSKEY, M., ALI, R., RITTER, A., & COOKE, R. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500286039 · Cited by 226
Rutten-van Mölken, M. P. M. H., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006) · Chest · doi:10.1378/chest.130.4.1117 · Cited by 198
Violent traumatic events and drug abuse severity
Clark, H. W., Masson, C. L., Delucchi, K., Hall, S. M., & Sees, K. L. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(00)00156-2 · Cited by 184
The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients
Cacciola, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00148-4 · Cited by 181
Kidorf, M., Disney, E. R., King, V. L., Neufeld, K., Beilenson, P. L., & Brooner, R. K. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.014 · Cited by 178
Marsden, J., Gossop, M., Stewart, D., Rolfe, A., & Farrell, M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.3.285 · Cited by 161
Maremmani, I., Pani, P. P., Pacini, M., & Perugi, G. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.11.009 · Cited by 159
Coping with Type II diabetes: the patient’s perspective
Koopmanschap, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0861-2 · Cited by 158
Dijkgraaf, M. G. W., van der Zanden, B. P., de Borgie, C. A. J. M., Blanken, P., van Ree, J. M., & van den Brink, W. (2005) · BMJ · doi:10.1136/bmj.330.7503.1297 · Cited by 157
Prevalence and Consequences of Dual Diagnosis
Buckley, P. F., & Brown, E. S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0706e01 · Cited by 156
Depression in methadone maintenance treatment patients: Rate and risk factors
Peles, E., Schreiber, S., Naumovsky, Y., & Adelson, M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.09.017 · Cited by 154
Evidence-Based Treatment of Opioid-Dependent Patients
van den Brink, W., & Haasen, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101003 · Cited by 147
Generalizability of valuations on health states collected with the EuroQolc‐questionnaire
Essink‐Bot, M., Stouthard, M. E. A., & Bonsel, G. J. (1993) · Health Economics · doi:10.1002/hec.4730020307 · Cited by 143
Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS)
Havard, A., Teesson, M., Darke, S. G., & Ross, J. E. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.03.012 · Cited by 142
Puigdollers, E., Domingo‐Salvany, A., Brugal, M. T., Torrens, M., Alvarós, J., Castillo, C., Magrí, N., Martín, S., & Vázquez, J. M. (2004) · Substance Use & Misuse · doi:10.1081/ja-120039392 · Cited by 142
Prevalence of Psychiatric Disorder in a Methadone Maintenance Population
Callaly, T., Trauer, T., Munro, L., & Whelan, G. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/0004867010060507 · Cited by 138
Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
Buckley, P. F. (2006) · PubMed · Cited by 131
Teesson, M., Havard, A., Fairbairn, S., Ross, J. E., Lynskey, M. T., & Darke, S. G. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.12.001 · Cited by 125
A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis
Marra, C. A., Esdaile, J. M., Guh, D., Kopec, J. A., Brazier, J. E., Koehler, B. E., Chalmers, A., & Anis, A. H. (2004) · Medical Care · doi:10.1097/00005650-200411000-00012 · Cited by 123
Gelkopf, M., Bleich, A., Hayward, R., Bodner, G., & Adelson, M. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00175-6 · Cited by 118
van de Willige, G., Wiersma, D., Nienhuis, F. J., & Jenner, J. A. (2005) · Quality of Life Research · doi:10.1007/s11136-004-0689-y · Cited by 107
Treatment of patients with substance use disorders: Second edition
Kleber, H. D., Weiss, R. D., Anton, R. F., George, T. P., Greenfield, S. F., Kosten, T. R., O’Brien, C. P., Rounsaville, B. J., Strain, E. C., Ziedonis, D. M., et al. (2006) · American Journal of Psychiatry · Cited by 107
Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999) · PubMed Central · Cited by 97
König, H.-H., Roick, C., & Angermeyer, M. C. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2006.08.004 · Cited by 95
Epstein, D. H., & Preston, K. L. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00310.x · Cited by 94
Prevalence of psychiatric disorder in a methadone maintenance population
Callaly, T., Trauer, T., Munro, L., & Whelan, G. (2001) · Australian and New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00916.x · Cited by 94
Self-perceived Health Among Canadian Opiate Users
Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strıke, C., Myers, T., Shore, R., Hopkins, S., Raftis, S., & Pearson, M. (2004) · Canadian Journal of Public Health · doi:10.1007/bf03405775 · Cited by 93
Eyes Wide Shut? – A Conceptual and Empirical Critique of Methadone Maintenance Treatment
Fischer, B., Rehm, J., Kim, G., & Kirst, M. (2005) · European Addiction Research · doi:10.1159/000081410 · Cited by 81
McCance‐Katz, E. F. (2005) · Clinical Infectious Diseases · doi:10.1086/429503 · Cited by 77
STENBACKA, M., BECK, O., LEIFMAN, A., ROMELSJÖ, A., & HELANDER, A. (2007) · Drug and Alcohol Review · doi:10.1080/09595230601036994 · Cited by 75
Excessive alcohol consumption is associated with reduced quality of life among methadone patients
Senbanjo, R., Wolff, K., & Marshall, J. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01683.x · Cited by 71
Excessive alcohol consumption and drinking expectations among clients in methadone maintenance
Hillebrand, J., Marsden, J., Finch, E., & Strang, J. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00198-2 · Cited by 70
Mortality in heroin-assisted treatment in Switzerland 1994–2000
Rehm, J. T., Frick, U., Hartwig, C., Gutzwiller, F. F., Gschwend, P., & Uchtenhagen, A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.01.005 · Cited by 70
Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
Bramness, J., & Kornør, H. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.03.008 · Cited by 68
Millson, P., Challacombe, L., Villeneuve, P. J., Strike, C. J., Fischer, B., Myers, T., Shore, R., & Hopkins, S. (2006) · European Addiction Research · doi:10.1159/000090426 · Cited by 68
The Long-Term Outcomes of Drug Use by Methadone Maintenance Patients
BOVASSO, G. B., & Cacciola, J. (2003) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287318 · Cited by 63
Remission of Psychiatric Symptoms Among Drug Misusers After Drug Dependence Treatment
Gossop, M., Marsden, J., & Stewart, D. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000244483.17443.0e · Cited by 62
Karow, A., Verthein, U., Krausz, M. R., & Schäfer, I. (2008) · European Addiction Research · doi:10.1159/000110409 · Cited by 61
Influence of Antisocial Personality Subtypes on Drug Abuse Treatment Response
King, V., Kidorf, M., Stoller, K. B., Carter, J. A., & Brooner, R. (2001) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-200109000-00004 · Cited by 56
Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub2 · Cited by 52
Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
Kamal, F., Flavin, S., Campbell, F., Behan, C., Fagan, J., & Smyth, B. P. (2007) · PubMed · Cited by 48
Schreiber, S., Peles, E., & Adelson, M. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.016 · Cited by 47
Pouwer, F., & Adriaanse, M. C. (2003) · Diabetologia · doi:10.1007/s00125-002-1023-2 · Cited by 45
Psychiatric Comorbidity Is Associated With Drug Use and HIV Risk in Syringe Exchange Participants
Disney, E. R., KIDORF, M. S., Kolodner, K., King, V. L., Peirce, J. M., Beilenson, P. L., & Brooner, R. K. (2006) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000230396.17230.28 · Cited by 43
Predictive validity of cocaine, sedative, and alcohol dependence diagnoses.
KIDORF, M. S., Brooner, R. K., King, V. L., Stoller, K. B., & Wertz, J. S. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.1.168 · Cited by 42
Damen, K. F. M., de Jong, C. A. J., & van der Kroft, P. J. A. (2004) · European Addiction Research · doi:10.1159/000077697 · Cited by 41
Alcohol Consumption during Methadone Maintenance Treatment
Rittmannsberger, H., Silberbauer, C., Lehner, R., & Ruschak, M. (2000) · European Addiction Research · doi:10.1159/000019003 · Cited by 39
Krabbe, P. F. M., KONING, J., Heinen, N., Laheij, R. J. F., van Cauter, R. M. V., & de Jong, C. A. J. (2003) · Addiction Biology · doi:10.1080/13556210310001602275 · Cited by 37
Self-citationTeplin, D., O'Connell, T., Daiter, J., & Varenbut, M. (2004) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-200032270 · Cited by 35
Maremmani, I., Pacini, M., Pani, P. P., Perugi, G., Deltito, J. A., & Akiskal, H. S. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-31 · Cited by 35
Research Findings on Psychotherapy of Addictive Disorders
WOODY, G. E. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00553.x · Cited by 35
Phillips, J., Carpenter, K. M., & Nunes, E. V. (2004) · American Journal on Addictions · doi:10.1080/10550490490482973 · Cited by 30
Smyth, B., Fan, J., & Hser, Y. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n04_04 · Cited by 20
Addiction problems and methadone treatment.
Meulenbeek, P. (2000) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(00)00116-1 · Cited by 16
Screening for psychopathology in the clinical practice
Eland-Goossensen, A., van de Goor, I., Garretsen, H. F. L., & Schudel, J. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00186-4 · Cited by 15
Anti‐social personality disorder and response to methadone maintenance treatment
Darke, S. G., Finlay‐Jones, R., Kaye, S. S., & Blatt, T. (1996) · Drug and Alcohol Review · doi:10.1080/09595239600186011 · Cited by 15
Research works printed but not linked: 3
- Fischer B, 2001, Substitution: Zwischen Leben und Sterben, 21
- Pfohl B, Structured Interview for DSM‐IV Personality Disorders. 1‐9‐1997
- Szende A, 2008, Measuring self‐reported population health: an international perspective based on EQ‐5D
Cited by
Johansson, R., Carlbring, P., Heedman, Å., Paxling, B., & Andersson, G. (2013) · PeerJ · doi:10.7717/peerj.98 · Cited by 309
Maeyer, J. D., Vanderplasschen, W., Camfield, L., Vanheule, S., Sabbe, B., & Broekaert, E. (2011) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.03.009 · Cited by 179
Muller, A. E., Skurtveit, S. O., & Clausen, T. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0439-1 · Cited by 127
De Maeyer, J., Vanderplasschen, W., Lammertyn, J., van Nieuwenhuizen, C., Sabbe, B., & Broekaert, E. (2011) · Quality of Life Research · doi:10.1007/s11136-010-9732-3 · Cited by 102
Alho, H., Demattéis, M., Lembo, D., Maremmani, I., Roncero, C., & Somaini, L. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.102616 · Cited by 100
Metadata
- Authors
- Carpentier, P. J., Krabbe, P. F. M., Van Gogh, M. T., Knapen, L. J. M., Buitelaar, J. K., & De Jong, C. A. J.
- Affiliations
- Reinier van Arkel (NL)
- Radboud University Medical Center (NL)
- Corresponding author
- Carpentier, Pieter J.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2009-11-12
- Volume
- 18
- Issue
- 6
- Pages
- 470-480
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- OpenAlex
- W2153248065
- Cited by
- 138
- References
- 75
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 14 · 2020: 6 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 15 · 2012: 11
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal on Addictions (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- methadone maintenance treatment, opioid use disorder, psychiatric comorbidity, quality of life, mood disorders, anxiety disorders, personality disorders, antisocial personality disorder, substance use disorders, mental health services
- MeSH terms
- Adult, Antisocial Personality Disorder, Anxiety Disorders, Mental Disorders, Cross-Sectional Studies, Female, Heroin Dependence, Humans, Long-Term Care, Male, Methadone, Middle Aged, Narcotics, Netherlands, Patient Care Team, Quality of Life, Somatoform Disorders, Illicit Drugs, Comorbidity, Mood Disorders, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.